Your browser doesn't support javascript.
loading
In-house testing for homologous recombination repair deficiency (HRD) testing in ovarian carcinoma: a feasibility study comparing AmoyDx HRD Focus panel with Myriad myChoiceCDx assay.
Fumagalli, Caterina; Betella, Ilaria; Ranghiero, Alberto; Guerini-Rocco, Elena; Bonaldo, Giulio; Rappa, Alessandra; Vacirca, Davide; Colombo, Nicoletta; Barberis, Massimo.
Afiliação
  • Fumagalli C; Clinical Unit of Oncogenomics, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
  • Betella I; Division of Pathology, Department of Diagnostic Services, Azienda Socio Sanitaria Territoriale (ASST) Valle Olona, Gallarate, Italy.
  • Ranghiero A; Division of Gynecologic Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
  • Guerini-Rocco E; Clinical Unit of Oncogenomics, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
  • Bonaldo G; Clinical Unit of Oncogenomics, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
  • Rappa A; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Vacirca D; Division of Gynecologic Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
  • Colombo N; Clinical Unit of Oncogenomics, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
  • Barberis M; Clinical Unit of Oncogenomics, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Pathologica ; 114(4): 288-294, 2022 Aug.
Article em En | MEDLINE | ID: mdl-36136896

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteína BRCA2 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteína BRCA2 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article